![](/img/cover-not-exists.png)
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
Jathal, Maitreyee K., Steele, Thomas M., Siddiqui, Salma, Mooso, Benjamin A., D’Abronzo, Leandro S., Drake, Christiana M., Whang, Young E., Ghosh, Paramita M.Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-019-0496-4
Date:
June, 2019
File:
PDF, 2.53 MB
english, 2019